1. Home
  2. VOC vs CNTX Comparison

VOC vs CNTX Comparison

Compare VOC & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VOC

VOC Energy Trust Units of Beneficial Interest

HOLD

Current Price

$3.40

Market Cap

48.8M

Sector

Energy

ML Signal

HOLD

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

HOLD

Current Price

$0.63

Market Cap

51.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VOC
CNTX
Founded
2010
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.8M
51.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
VOC
CNTX
Price
$3.40
$0.63
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$6.60
AVG Volume (30 Days)
58.7K
4.4M
Earning Date
01-01-0001
05-08-2026
Dividend Yield
12.46%
N/A
EPS Growth
N/A
17.39
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.60
$0.55
52 Week High
$3.84
$3.62

Technical Indicators

Market Signals
Indicator
VOC
CNTX
Relative Strength Index (RSI) 72.46 32.52
Support Level $3.30 $0.55
Resistance Level $3.58 $0.70
Average True Range (ATR) 0.10 0.06
MACD 0.04 0.06
Stochastic Oscillator 96.45 47.29

Price Performance

Historical Comparison
VOC
CNTX

About VOC VOC Energy Trust Units of Beneficial Interest

VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust. It operates in a single operating and reportable segment.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: